Seattle-based Accolade is set to go private again in a deal to be acquired by Transcarent that brings together ...

Life and health insurer MetLife (NYSE:MET) announced on Wednesday that its institutional asset management business is set to ...

Transcarent CEO Glen Tullman spent much of 2024 hinting that his health benefits upstart might be shopping around for ...

Employee healthcare navigation company Transcarent plans to acquire health benefits platform Accolade in a deal valued at ...

Transcarent, which connects self-insured employer customers to behavioral health, urgent care, cancer care, pharmacy and ...

MetLife Investment Management, the institutional asset management arm of MetLife Inc., has signed a definitive agreement to ...

Inari makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be ...

Transcarent agreed to acquire healthcare company Accolade for $7.03 a share in cash, bringing the equity value of the deal to around $621 million.